Drug details

Agrylin (anagrelide)

type of Antiplatelet Agents, Hematologic

Agrylin (anagrelide hydrochloride) is a platelet-reducing agent used to treat thrombocythemia (also called thrombocytosis), a blood cell disorder in which too many platelet cells are produced, causing bleeding or blood-clotting problems. Agrylin is available in generic form.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• easy bruising,
• shortness of breath,
• fluttering in your chest,
• chest pain or pressure,
• unusual bleeding (nosebleeds, bleeding gums),
• bloody or tarry stools,
• coughing up blood,
• vomit that looks like coffee grounds,
• fast or pounding heartbeats,
• sudden dizziness,
• swelling in your lower legs, and
• blue colored lips or skin

The following drugs are related to Agrylin, either as a replacement or used together:

• Arixtra (fondaparinux sodium)
• Iprivask (desirudin for injection)
• Lovenox (enoxaparin sodium injection)
• Hydrea (hydroxyurea)